Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) -
Pharmaceutical Innovations, Inc. began a recall of Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) - Product Usage: A gel pad for use on woman s areola during... on . FDA classified it as Class II and gives the reason as "The firm registered the product as a Class I device, but has since been informed by FDA that the device is not Class I and requires a 510(k) submission". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-2830-2020
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Pharmaceutical Innovations, Inc.
- Product
- Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) - Product Usage: A gel pad for use on woman s areola during an ultrasound examination. Its primary purpose is for patient comfort over the loose gel and helps with nipple location during the scan, making the areola location easier to identify.
- Product code
- MUI Media, Coupling, Ultrasound
- Reason for recall
- The firm registered the product as a Class I device, but has since been informed by FDA that the device is not Class I and requires a 510(k) submission.
- FDA root cause
- No Marketing Application
- Action
- On 8/13/2020, the firm distributed Urgent Medical Device Recall letters to its distributor, with instructions to notify all affected customers who received the product. Customers were informed that the product had been misclassified by the firm and required a 510(k) submission to FDA. Customers were instructed to identify and quarantine the products, and to cease use and sales of the product. Customers are to complete the included response form and return it to the firm. The firm will issue a Return Material Authorization for the return of the product. No option will be given to destroy product in the field. Customers should notify all users within their facility as well as any downstream accounts if the product has been further distributed/ transferred.
- Quantity in commerce
- tbd
- Distribution
- US Nationwide distribution including in the state of Nevada.
- Product codes and lots
- Lots 021805-02 030805-02 050405-02 051106-02 052406-02 101006-02 101806-02 103406-02 052708-02 053308-02 060308-02 111208-02 111908-02 112108-02 050309-02 050809-02 101009-02 101309-02 061310-02 061710-02 061910-02 021411-02 021911-02 030211-02 030711-02 070711-02 113211-02 113311-02 011312-02 022112-02 030412-02 030812-02 061712-02 061912-02 070512-02 120612-02 011013-02 011313-02 021413-02 030313-02 051313-02 052713-02 060113-02 120613-02 011414-02 021314-02 022614-02 030614-02 060914-02 061314-02 062014-02 070714-02 100314-02 101614-02 110914-02 120314-02 020115-02 030115-02 060615-02 061315-02 070515-02 070815-02 100315-02 100615-02 110315-02 110715-02 120316-02 010416-02 011316-02 020216-02 021016-02 030516-02 052016-02 060316-02 091416-02 092316-02 100616-02 101516-02 102116-02 020517-02 021617-02 030817-02 031517-02 032417-02 040717-02 041017-02 050617-02 060317-02 071217-02 071917-02 080417-02 081717-02 091017-02 091617-02 092317-02 100517-02 021018-02 031318-02 040418-02 040718-02 041118-02 041318-02 041818-02 051218-02 060718-02 020619-02 020919-02
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2830-2020 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
